VCM
VIVO

Versant Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Versant Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-909
Closed -$24K – 1643
2021
Q1 		$24K Sell
909
-369
-29% -$8.77K 0.01% 506
2020
Q4 		$23K Sell
1,278
-59
-4% -$1.1K 0.01% 473
2020
Q3 		$22K Sell
1,337
-5
-0.4% -$97 0.01% 406
2020
Q2 		$31K Hold
1,342
– – 0.01% 308
2020
Q1 		$11K Buy
+1,342
New +$11.3K 0.01% 535
2019
Q2 		– Sell
-209
Closed -$3K – 1797
2019
Q1 		$3K Sell
209
-689
-77% -$11.5K ﹤0.01% 1294
2018
Q4 		$15K Sell
898
-18
-2% -$307 0.01% 669
2018
Q3 		$13K Sell
916
-286
-24% -$4.43K 0.01% 824
2018
Q2 		$19K Sell
1,202
-211
-15% -$3.15K 0.01% 652
2018
Q1 		$20K Sell
1,413
-28
-2% -$414 0.01% 639
2017
Q4 		$20K Buy
1,441
+189
+15% +$2.77K 0.01% 666
2017
Q3 		$17K Sell
1,252
-833
-40% -$11.9K 0.01% 669
2017
Q2 		$32K Buy
2,085
+1,136
+120% +$16.4K 0.02% 388
2017
Q1 		$13K Buy
949
+644
+211% +$9.01K 0.01% 757
2016
Q4 		$5K Hold
305
– – ﹤0.01% 1037
2016
Q3 		$5K Sell
305
-46
-13% -$900 ﹤0.01% 1007
2016
Q2 		$6K Sell
351
-3
-0.8% -$59 ﹤0.01% 936
2016
Q1 		$7K Sell
354
-1,543
-81% -$30.4K ﹤0.01% 889
2015
Q4 		$38K Buy
+1,897
New +$36.4K 0.02% 301

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Versant Capital Management's VIVO Position: Q2 2021 in Review

Versant Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 909 shares — an estimated $24K sold.

Versant Capital Management first reported a position in VIVO in Q4 2015 and held it in 19 quarters. The position peaked at $38K in Q4 2015. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Versant Capital Management reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Versant Capital Management sold 909 Meridian Bioscience Inc shares in Q2 2021, an estimated $24K.
  • Versant Capital Management first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 19 quarters.
  • Versant Capital Management's Meridian Bioscience Inc position peaked at $38K in Q4 2015.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Versant Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.